Débora González
Since 2012, I have been researching the potential of altered states of consciousness in the grieving processes following the loss of a loved one.
-
Ketamine: chronology of a clinical revolution
Ketamine’s clinical journey spans more than six decades, evolving from a battlefield anesthetic to a groundbreaking therapeutic tool in mental health. Its history reflects a convergence of neurobiological discovery, clinical intuition, and…
-
The potential of ayahuasca assisted with psychotherapy in acute grief processes: a scientific and artistic exploration
Recent research suggests ayahuasca-assisted psychotherapy may support people facing acute grief. In a structured therapeutic setting, ayahuasca was associated with reduced grief severity, fewer prolonged-grief symptoms, and greater post-traumatic growth. The study…
-
Neuroplasticity and ketamine: a new horizon in mental health
Depression, anxiety and chronic stress are associated with the loss and retraction of dendritic spines, disrupting communication between key brain regions involved in emotion, memory and decision-making. This disconnection reduces cognitive flexibility…
-
Ketamine for Treatment Resistant Depression: Real World Evidence
Treatment-resistant depression affects up to one third of patients with major depressive disorder and is linked to severe impairment and suicide risk. Real-world clinical data show that ketamine offers rapid antidepressant effects,…
-
Prolonged Bereavement
Grief after the death of a loved one is a universal experience, yet for some people it becomes prolonged, intense, and deeply disabling. Prolonged grief is associated with persistent yearning, emotional pain,…
-
Ketamine-assisted therapy in the treatment of grief for the loss of a loved one
Prolonged or complicated grief affects around 10% of bereaved people and is marked by persistent longing, intense emotional distress, and functional impairment. Current evidence shows only moderate benefits from psychotherapy and no…